Allele- and locus-specific recognition of class I MHC molecules by the immunomodulatory E3-19K protein from adenovirus

Journal of Immunology

Volumn 178, Issue 7, 2007, Pages 4567-4575

  Liu, Hong ^a   Fu, Jie ^a   Bouvier, Marlene ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN E3 19K; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADENOVIRUS; ALLELE; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; DISSOCIATION CONSTANT; ENDOPLASMIC RETICULUM; FLOW CYTOMETRY; GEL ELECTROPHORESIS; GEL FILTRATION CHROMATOGRAPHY; GENE LOCUS; HUMAN; HUMAN CELL; INFECTION SENSITIVITY; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; SURFACE PLASMON RESONANCE;

EID: 33947622234     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.7.4567     Document Type: Article

References (43)

1. Horwitz, M. S. 1990. Adenoviruses. In Virology, 2nd ed. B. N. Fields, D. M. Knipe, R. M. Chanock, M. S. Hirsch, J. L. Melnick, T. P. Monath, and B. Roizman, eds. Raven Press, New York, NY, pp. 1723-1763.
2. Wold, W. S. M., and L. R. Gooding. 1991. Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions. Virology 184: 1-8.
3. Horwitz, M. S. 1990. Adenoviruses. In Virology, 2nd ed. B. N. Fields, D. M. Knipe, R. M. Chanock, M. S. Hirsch, J. L. Melnick, T. P. Monath, and B. Roizman, eds. Raven Press, New York, NY, pp. 1679-1721.
4. Vasavada, R., K. Eager, G. Barbani-Brodono, A. Caputo, and R. Ricciardi. 1986. Adenovirus type 12 early region IA proteins repress class I HLA expression in transformed human cells. Proc. Natl. Acad. Sci. USA 83: 5257-5261.
5. Rotem-Yehudar, R., M. Groettrup, A. Soza, P. M. Kloetzel, and R. Ehrlich. 1996. LMP-associated proteolytic activities and TAP-dependent peptide transport for class I molecules are suppressed in cell lines transformed by the highly oncogenic adenovirus 12. J. Exp. Med. 183: 499-514.
6. Burgert, H.-G., and S. Kvist. 1985. An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens. Cell 41: 987-997.
7. Burgert, H.-G., and S. Kvist. 1987. The E3/19K protein of adenovirus type 2 binds to the domains of histocompatibility antigens required for CTL recognition. EMBO J. 6: 2019-2026.
8. Cox, J. H., J. W. Yewdell, L. C. Eisenlohr, P. R. Johnson, and J. R. Bennink. 1990. Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum. Science 247: 715-718.
9. Kvist, S., L. Ostberg, H. Persson, L. Philipson, and P. A. Peterson. 1978. Molecular association between transplantation antigens and cell surface antigen in adenovirus-transformed cell line. Proc. Natl. Acad. Sci. USA 75: 5674-5678.
10. Bennett, E. M., J. R. Bennink, J. W. Yewdell, and F. M. Brodsky. 1999. Cutting edge: adenovirus E19 has two mechanisms for affecting class I MHC expression. J. Immunol. 162: 5049-5052.
11. Lichtenstein, D. L., K. Torn, K. Doronin, A. E. Tollefson, and W. S. M. Wold. 2004. Functions and mechanisms of action of the adenovirus E3 proteins. Int. Rev. Immunol. 23: 75-111.
12. Andersson, M., T. Paabo, T. Nilsson, and P. A. Peterson. 1985. Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance. Cell 43: 215-222.
13. + T-cell responses are not inhibited by E3-19K in the presence of γ interferon. J. Virol. 70: 6314-6322.
14. Rawle, F. C., A. E. Tollefson, W. S. M. Wold, and L. R. Gooding. 1989. Mouse anti-adenovirus cytotoxic T lymphocytes. J. Immunol. 143: 2031-2037.
15. Andersson, M., A. McMichael, and P. A. Peterson. 1987. Reduced allorecognition of adenovirus-2 infected cells. J. Immunol. 138: 3960-3966.
16. Ginsberg, H. S., U. Lundholm-Beauchamp, R. L. Horswood, B. Pernis, W. S. M. Wold, R. M. Chanock, and G. A. Prince. 1989. Role of early region 3 (E3) in pathogenesis of adenovirus disease. Proc. Natl. Acad. Sci. USA 86: 3823-3827.
17. Beier, D. C., J. H. Cox, D. R. Vining, P. Cresswell, and V. H. Engelhard. 1994. Association of human class 1 MHC alleles with the adenovirus E3/19K protein. J. Immunol. 152: 3862-3872.
18. Feuerbach, D., S. Etteldorf, C. Ebenau-Jehle, J.-P. Abastado, D. Madden, and H.-G. Burgert. 1994. Identification of amino acids within the MHC molecule important for the interaction with the adenovirus protein E3/19K. J. Immunol. 153: 1626-1636.
19. Flomenberg, P., E. Gutierrez, and K. T. Hogan. 1994. Identification of class I MHC regions which bind to the adenovirus E3-19K protein. Mol. Immunol. 31: 1277-1284.
20. Liu, H., W. F. Stafford, and M. Bouvier. 2005. The endoplasmic reticulum lumenal domain of the adenovirus type 2 E3-19K binds to peptide-filled and peptide-deficient HLA-A*1101 molecules. J. Virol. 79: 13317-13325.
21. Cox, J. H., J. R. Bennink, and J. W. Yewdell. 1991. Retention of adenovirus E19 glycoprotein in the endoplasmic reticulum is essential to its ability to block antigen presentation. J. Exp. Med. 174: 1629-1637.
22. Paabo, S., B. M. Bhat, W. S. M. Wold, and P. A. Peterson. 1987. A short sequence in the COOH-terminus makes an adenovirus membrane glycoprotein a resident of the endoplasmic reticulum. Cell 50: 311-317.
23. Severinsson, L., I. Martens, and P. A. Peterson. 1986. Differential association between two human MHC class I antigens and an adenoviral glycoprotein. J. Immunol. 137: 1003-1009.
24. Deryckere, F., and H.-G. Burgert. 1996. Early region 3 of adenovirus type 19 (subgroup D) encodes an HLA-binding protein distinct from that of subgroups B and C. 1996. J. Virol. 70: 2832-2841.
25. Korner, H., and H.-G. Burgert. 1994. Down-regulation of HLA antigens by the adenovirus type 2 E3/19K protein in a T-lymphoma cell line. J. Virol. 68: 1442-1448.
26. Li, L., and M. Bouvier. 2005. Biochemical and structural impact of natural polymorphism in the HLA-A3 superfamily. Mol. Immunol. 41: 1331-1344.
27. 2m heterodimer. Nat. Struct. Biol. 5: 377-382.
28. Garboczi, D. N., D. T. Hung, and D. C. Wiley. 1992. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc. Natl. Acad. Sci. USA 89: 3429-3433.
29. Kelly, T. J., and A. M. Lewis, Jr. 1973. Use of nondefective adenovirussimian virus 40 hybrids for mapping the simian virus 40 genome. J. Virol. 12: 643-652.
30. Sriwanthana, B., T. Hodge, T. D. Mastro, C. S. Dezzutti, K. Bond, H. A. F. Stephens, L. G. Kostrikis, K. Limpakarnjanarat, N. L. Young, S. H. Qari, et al. 2001. HIV-specific cytotoxic T lymphocytes, HLA-A11, and chemokine-related factors may act synergistically to determine HIV resistance in CCR5 Δ32-negative female sex workers in Chiang Rai, Northern Thailand. AIDS Res. Hum. Retroviruses 17: 719-734.
31. Wang, R.-F., S. L. Johnston, S. Southwood, A. Sette, and S. A. Rosenberg. 1998. Recognition of an antigenic peptide derived from tyrosinase-related protein-2 by CTL in the context of HLA-31 and -A33. J. Immunol. 160: 890-897.
32. Huczko, E. L., W. M. Bodnar, D. Benjamin, K. Sakaguchi, N. Z. Zhu, J. Shabanowitz, R. A. Henderson, E. Appella, D. F. Hunt, and V. H. Engelhard. 1993. Characteristics of endogenous peptides eluted from the class I MHC molecules HLA-B7 determined by mass spectrometry and computer modeling. J. Immunol. 151: 2572-2587.
33. Burrows, S. R., S. J. Rodda, A. Suhrbier, H. M. Geysen, and D. J. Moss. 1992. The specificity of recognition of a cytotoxic T lymphocyte epitope. Eur. J. Immunol. 22: 191-195.
34. Zappacosta, F., F. Borrego, A. G. Brooks, K. C. Parker, and J. Coligan. 1997. Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis. Proc. Natl. Acad. Sc. USA 94: 6313-6318.
35. Sidney, J., M.-F. del Guercio, S. Southwood, V. H. Engelhard, E. Appella, H.-G. Rammensee, K. Falk, O. Rotzschke, M. Takiguchi, R. T. Kubo, et al. 1995. Several HLA alleles share overlapping peptide specificities. J. Immunol. 154: 247-259.
36. Flomenberg, P., E. Gutierrez, and K. T. Hogan. 1994. Identification of class I MHC regions which bind to the adenovirus E3-19K protein. Mol. Immunol. 31: 1277-1284.
37. Ishido, S., C. Wang, B.-S. Lee, G. B. Cohen, and J. U. Jung. 2000. Downregulation of major histocompatibility complex class I molecules by kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J. Virol. 74: 5300-5309.
38. Gewurz, B. E., E. W. Wang, D. Tortorella, D. J. Schust, and H. L. Ploegh. 2001. Human cytomegalovirus US2 endoplasmic reticulum-lumenal domain dictates association with major histocompatibility complex class I in a locus-specific manner. J. Virol. 75: 5197-5204.
39. Cohen, G. B., R. T. Gandhi, D. M. Davis, O. Mandelboim, B. K. Chen, J. L. Strominger, and D. Baltimore. 1999. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells Immunity 10: 661-671.
40. Bouvier, M. 2003. Accessory proteins and the assembly of human class I MHC molecules: a molecular and structural perspective. Mol. Immunol. 39: 697-706.
41. Gewurz, B. E., R. Gaudet, D. Tortorella, E. W. Wang, H. L. Ploegh, and D. C. Wiley. 2001. Antigen presentation subverted: structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2. Proc. Natl. Acad. Sci. USA 98: 6794-6799.
42. Thilo, C., P. Berglund, S. E. Applequist, J. W. Yewdell, H.-G. Ljunggren, and A. Achour. 2006. Dissection of the interaction of the human cytomegalovirus-derived US2 protein with major histocompatibility complex class I molecules. J. Biol. Chem. 281: 8950-8957.
43. Li, L., and M. Bouvier. 2004. Structures of HLA-A*1101 complexed with immunodominant nonamer and decamer HIV-1 epitopes clearly reveal the presence of a middle, secondary anchor residue. J. Immunol. 172: 6175-6184.